Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-05

Clinical Trial Update: Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection

View source ↗

Summary

Clinical trial update on BIOMONITOR utility for identifying atrial fibrillation in ablation candidates; study terminated with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIOMONITOR

Snippet

Sponsor: Biotronik, Inc. | Conditions: Atrial Fibrillation | Status: TERMINATED | Results posted: 2022-04-05